Systematic diagnostic workup of new ICU fever (T ≥ 38.3°C): line and device screening, pulmonary/abdominal/urinary source triage, distinguishing infectious vs non-infectious fever, and rational blood culturing.
New-onset fever (core body temperature ≥ 38.3°C / 101.0°F) in an ICU patient is a daily clinical dilemma. While fever frequently signals nosocomial bacterial infection (VAP, CRBSI, CAUTI, C. difficile, surgical site infection), up to 30–50% of new ICU fevers are non-infectious (drug fever, DVT/PE, transfusion reaction, acute pancreatitis, intracranial fever). The bedside task is to screen for severe sepsis/septic shock, systematically inspect all lines and invasive devices, and obtain rational microbiological diagnostics before unguided antibiotic escalation.
Caution
Dangerous Diagnosis Not to Miss: Necrotizing Soft Tissue Infection (NSTI / Fournier gangrene; severe pain out of proportion to exam, skin bullae, subcutaneous crepitus), Catheter-Related Bloodstream Infection with Septic Shock, Acute Intra-Abdominal Disaster (perforated viscus, anastomotic leak), and Malignant Hyperthermia / Neuroleptic Malignant Syndrome / Serotonin Syndrome.
Measure Core Temperature: Esophageal, bladder, or rectal thermometry (axillary/temporal measurements are notoriously inaccurate in ICU shock states).
Hemodynamic Screen for Sepsis: Check for new hypotension (MAP < 65), acute tachypnea, rising oxygen requirement, altered mental status, or rising serum lactate.
Immediate Danger Signs: Mottled skin, purpura fulminans, severe unexplained metabolic acidosis, rapidly expanding erythema with blister formation.
Wind (Pulmonary): Ventilator-Associated Pneumonia (VAP) or Hospital-Acquired Pneumonia (HAP); purulent endotracheal secretions, new or progressive pulmonary infiltrates on CXR, worsening PaO2/FiO2 ratio.
Water (Urinary Tract): Catheter-Associated Urinary Tract Infection (CAUTI); cloudy urine, suprapubic tenderness (note: asymptomatic pyuria/candiduria in catheterized patients is common colonization and rarely causes fever alone).
Wound (Surgical Sites & Skin): Surgical incisions, sternotomy, drains, decubitus pressure ulcers, cellulitis, necrotizing fasciitis (probe wounds, inspect under dressings).
Waves / Wire (Vascular Catheters): Central Venous Catheter (CVC), hemodialysis lines, arterial lines (inspect insertion sites for erythema, induration, purulence; check catheter dwell time).
What did we do? (Drugs & Transfusions): Drug-induced fever (beta-lactams, anticonvulsants, heparin-induced), acute hemolytic or febrile non-hemolytic transfusion reactions, acute acalculous cholecystitis, C. difficile colitis (watery diarrhea, leukocytosis).
Blood Cultures: Draw at least 2 sets of blood cultures (1 set peripheral venipuncture + 1 set from each lumen of indwelling central lines) PRIOR to initiating/modifying antimicrobials; calculate differential time to positivity (DTP).
Endotracheal Aspirate (ETA) / Sputum: Quantitative or semiquantitative Gram stain and bacterial culture.
Urinalysis & Urine Culture: Specimen collected from newly placed catheter or aspiration port (never from drainage bag).
Stool Clostridioides difficile PCR & Toxin EIA: If watery diarrhea (≥ 3 loose stools in 24h) or unexplained leukocytosis.
Diagnostic Imaging: Portable CXR; Bedside POCUS (gallbladder for cholecystitis, DVT compression ultrasound, pleural effusions); CT Abdomen/Pelvis if intra-abdominal source is suspected.
Caution
Common Diagnostic Trap: Reflexively adding broad-spectrum Vancomycin and Meropenem for every single fever spike without examining the patient, inspecting surgical wounds, or considering non-infectious causes (e.g. DVT, drug fever, pancreatitis, post-operative systemic inflammatory response). This drives antimicrobial resistance and C. difficile infections without improving clinical outcomes.
Sepsis & Septic Shock: SSC guidelines, bundle delivery, and lactate clearance.
VAP & HAP: Diagnostic thresholds, quantitative cultures, and 7-day de-escalation.
Catheter Infections: Differential time to positivity, line salvage vs removal, and catheter lock therapy.
C. difficile: Toxin assays, oral vancomycin/fidaxomicin, and surgical triggers for toxic megacolon.
Antimicrobial Stewardship: PK/PD beta-lactam infusions and rapid molecular diagnostic interpretation.
Evidence status
Review metadata not yet recorded.
Status, review dates and guideline versions appear here once editorial metadata is authored for this content.
From recognizing hypoperfusion and initial crystalloid bolus to dynamic fluid responsiveness assessment and vasopressor targets.
From first-line norepinephrine titration to multi-agent vasopressor escalation and inotrope selection.
From multi-vasopressor failure to rescue non-adrenergic agents and mechanical circulatory support.
From confirming true hypotension to recognizing shock and its likely category.
Life-threatening organ dysfunction caused by a dysregulated host response to infection — recognized by an acute rise in SOFA score, not by infection plus fever alone.
The subset of sepsis with profound circulatory and cellular/metabolic abnormality — clinically identified by a vasopressor requirement to maintain MAP ≥ 65 mmHg plus lactate > 2 mmol/L despite adequate fluid resuscitation.
Quantitative lower tract sampling (ETA vs BAL), rapid multiplex PCR panels and stewardship interpretation, PK/PD extended beta-lactams, 7-day duration, and the SHEA prevention bundle.
Nosocomial pneumonia developing ≥ 48 hours after admission in non-ventilated patients, host and antibiogram MDR risk tailoring, nasal MRSA PCR screening, and 7-day de-escalation.
Molecular resistance mechanisms (ESBL, AmpC, KPC, NDM, OXA-48, DTR-Pseudomonas, CRAB), the MERINO trial, and modern novel beta-lactamase inhibitor therapeutics.
A surgical source-control emergency: recognize rapidly progressive deep infection, involve surgery immediately, start broad antimicrobials, resuscitate shock, and re-explore until source control is complete.
CT-before-LP criteria, CSF interpretation matrix, de Gans Dexamethasone timing, empiric age/host antimicrobial coverage + Ampicillin + Acyclovir, and neurocritical ICP management.